Verified employee & interview reviews

Siemens Healthineers Reviews

Erlangen, Germany

4.3/ 5

3 reviews

Siemens Healthineers is a leading global medical technology company headquartered in Erlangen, Germany, with a long history of innovation in healthcare engineering. Formally established in its current iteration after being spun off from its parent conglomerate, Siemens AG, in 2017 (which still maintains a majority 75% stake), the company’s foundational roots date back to mid-19th-century Berlin. Originally known as Siemens Healthcare, Siemens Medical Solutions, and Siemens Medical Systems, the company rebranded to Siemens Healthineers in May 2016 before executing a successful public listing on the Frankfurt Stock Exchange in March 2018. Operating internationally in over 70 countries and delivering products and clinical consulting services to healthcare providers across more than 180 countries, Siemens Healthineers is dedicated to pioneering breakthroughs that improve patient outcomes while lowering care costs. The company employs a massive global workforce of approximately 74,000 highly dedicated professionals, including specialized talent in medical engineering, digital data frameworks, and clinical research analytics. The extensive operational portfolio of Siemens Healthineers is structurally divided into four core business segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment stands as a dominant market leader, developing cutting-edge equipment for magnetic resonance imaging (MRI), computed tomography (CT) scanners, molecular imaging, X-ray installations, and high-performance ultrasound systems. The Diagnostics segment covers a comprehensive array of testing disciplines, specializing in laboratory automation, workflow informatics, immunochemistry, hematology, and point-of-care diagnostic products. The Advanced Therapies segment focuses on image-guided, minimally invasive surgical treatments, providing highly precise angiography systems and mobile C-arms to optimize workflows in cardiology and interventional radiology. A pivotal milestone in the company’s modern growth strategy occurred in 2021 when Siemens Healthineers acquired Varian Medical Systems Inc., integrating specialized oncology infrastructure into its portfolio. The Varian segment serves end-to-end multi-modality cancer care technologies, delivering advanced radiation oncology solutions, digital therapy management applications, and high-precision targeting tools like HyperSight imaging to departments globally. To fuel its continuous engineering excellence, Siemens Healthineers channels massive capital into innovation, including annual research and development investments reaching roughly EUR 1.5 billion. The company manages a vast intellectual property portfolio containing over 24,000 technical rights and more than 15,000 granted patents. Led globally by President and Chief Executive Officer Dr. Bernhard Montag, the company focuses closely on strategic pillars such as Healthcare AI, digital patient twinning, and value-based care optimization. By prioritizing scalable, tailored technologies, Siemens Healthineers aims to address critical clinical decision-making barriers, mitigate workforce shortages, and expand equitable access to high-value care pathways for global populations facing cardiovascular, neurodegenerative, and oncological diseases.